Skip to content

Web questionnaire survey on cancer cachexia

Web questionnaire survey on cancer cachexia - J-EPOCC(Japanese Evidence for Patients Of Cancer Cachexia)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037236
Enrollment
2000
Registered
2019-07-07
Start date
2019-07-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer cachexia

Interventions

None listed

Sponsors

Ono Pharmaceutical CO, LTD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Doctor who treats cancer patient of drug treatment stage of any of lung, gastric, esophageal, colorectal, liver, biliary, pancreatic cancer in more than 5 cases in the last 3 months Medical staff such as nurses, pharmacists, nutritionist and physical therapists who are involved in cancer treatment (except nurses who work in clinics and clinics) Patients with lung, gastric, esophageal, colorectal, liver, biliary, or pancreatic cancer who have been admitted to a medical institution for cancer treatment within one year and have a history of hospitalization. For patients who have lung, gastric, esophageal, colorectal, liver, biliary or pancreatic cancer and who have been hospitalized or visited a medical institution for cancer treatment within one year, Family of over 20 years old

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
1) Daily assessment and measurement of anorexia and weight loss associated with cancer 2) Treatment status for anorexia and weight loss 3) Understanding and treatment status of cancer cachexia diagnostic criteria

Countries

Japan

Contacts

Public ContactMika Shiya

Reno Medical K.K Account Executive

research_support@reno.co.jp03-6229-8960

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026